Radioprotectors in treatment therapy to reduce risk in secondary tumor induction-Reference-Cited by-同舟云学术

Radioprotectors in treatment therapy to reduce risk in secondary tumor induction

Published:1988-01 Issue:1-3 Volume:39 Page:21-25
ISSN:0163-7258
Container-title:Pharmacology & Therapeutics
language:en
Short-container-title:Pharmacology & Therapeutics

Author:

Grdina David J.,Nagy Biserka,Sigdestad Curtis P.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference22 articles.

1. Acute myelogenous leukemia as a second malignant neoplasm following the successful treatment of advanced Hodgkin's disease;Bartolucci;Cancer,1983

2. Modifiers of free radicals inhibit in vitro the oncogenic actions of X-rays, bleomycin, and the tumor promotor 12-O-tetradecanoylphorbol-13-acetate;Borek,1983

3. Increased incidence of acute nonlymphocytic leukemia following therapy in patients with small cell carcinoma of the lung;Chak;J. Clin. Oncol.,1984

4. Second cancers following antineoplastic therapy;Dorr;Curr. Probl. Cancer,1985

5. The effect of 2-[(aminopropyl)aminol] ethanethiol (WR-1065) on radiation-induced DNA damage and repair and cell progression in V79 cells;Grdina;Br. J. Cancer,1986

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. WR1065 conjugated to thiol-PEG polymers as novel anticancer prodrugs: broad spectrum efficacy, synergism, and drug resistance reversal;Frontiers in Oncology;2023-07-28

2. Repurposing of Various Current Medicines as Radioprotective Agents;Anti-Cancer Agents in Medicinal Chemistry;2023-06

3. Chemical radioprotective substances: The past, the present and the future;Kontakt;2006-05-26

4. Medical Treatment of Radiological Casualties: Current Concepts;Annals of Emergency Medicine;2005-06

5. Amifostine in clinical oncology: current use and future applications;Anti-Cancer Drugs;2002-03